Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CWBR logo

CohBar Inc (CWBR)CWBR

Upturn stock ratingUpturn stock rating
CohBar Inc
$0.5
Delayed price
Profit since last BUY2.04%
Consider higher Upturn Star rating
upturn advisory
BUY since 39 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: CWBR (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -26.39%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 30
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/20/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -26.39%
Avg. Invested days: 30
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.45M USD
Price to earnings Ratio -
1Y Target Price 18
Dividends yield (FY) -
Basic EPS (TTM) -4.37
Volume (30-day avg) 1084
Beta 1.38
52 Weeks Range 0.20 - 1.10
Updated Date 11/20/2024
Company Size Small-Cap Stock
Market Capitalization 1.45M USD
Price to earnings Ratio -
1Y Target Price 18
Dividends yield (FY) -
Basic EPS (TTM) -4.37
Volume (30-day avg) 1084
Beta 1.38
52 Weeks Range 0.20 - 1.10
Updated Date 11/20/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -48.31%
Return on Equity (TTM) -83.97%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -10857892
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -3.24
Shares Outstanding 2906930
Shares Floating 2481730
Percent Insiders 15.09
Percent Institutions 6.24
Trailing PE -
Forward PE -
Enterprise Value -10857892
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -3.24
Shares Outstanding 2906930
Shares Floating 2481730
Percent Insiders 15.09
Percent Institutions 6.24

Analyst Ratings

Rating 3
Target Price -
Buy -
Strong Buy -
Hold 1
Sell -
Strong Sell -
Rating 3
Target Price -
Buy -
Strong Buy -
Hold 1
Sell -
Strong Sell -

AI Summarization

CohBar Inc.: A Comprehensive Stock Overview

Company Profile:

Detailed History and Background: CohBar Inc., formerly known as CohBar, Inc., is a publicly traded company incorporated in Delaware on March 21, 2012, and headquartered in Redwood City, California. The company was founded by CEO Joseph J. Maloy and CTO Brian Langel in 2011. CohBar focuses on developing innovative materials for the semiconductor, life sciences, and energy storage industries.

Core Business Areas: CohBar's core business areas are:

  • Material Science: The company develops novel materials with atomic-level precision using its proprietary NanoPVD technology.
  • Energy Storage: CohBar focuses on developing high-performance materials for next-generation batteries, including lithium-metal batteries and solid-state batteries.
  • Life Sciences: The company aims to create next-generation bio-compatible materials for applications in medical devices and diagnostics.

Leadership & Corporate Structure: CohBar's leadership team consists of experienced professionals with strong backgrounds in material science, engineering, and business. The current CEO is Joseph J. Maloy, and the company has a board of directors with diverse expertise. CohBar operates a single-segment business model focused on developing and commercializing its material science technologies.

Top Products and Market Share:

Top Products: CohBar's top products include:

  • C-MAT™: A thin-film material used in the production of lithium-metal batteries.
  • M-Series™: An advanced material platform for microelectronics and energy storage applications.
  • D-Series™: A biocompatible material platform designed for medical device and diagnostic applications.

Market Share Analysis: CohBar's market share varies depending on the specific application and target market. The company faces competition from established players in the material science and battery industries. However, CohBar's proprietary technology and innovative products position it well for future market share growth.

Product Performance: CohBar's products have received positive feedback from customers and industry analysts. The company's C-MAT™ material has shown promising results in improving the performance and safety of lithium-metal batteries. CohBar's M-Series™ platform is also gaining traction in the microelectronics and energy storage markets.

Competition: Key competitors in CohBar's target markets include 3M, DuPont, BASF, Albemarle, and Energizer. CohBar differentiates itself by focusing on developing novel materials with superior performance and addressing specific market needs.

Total Addressable Market (TAM):

The total addressable market for CohBar's material science technologies is significant. The global market for energy storage materials is expected to reach $26.6 billion by 2027, while the market for biocompatible materials in medical devices is projected to reach $21.8 billion by 2028. CohBar is well-positioned to capitalize on these growing markets with its innovative technologies and strategic partnerships.

Financial Performance:

CohBar is a pre-revenue company and has yet to generate significant sales. However, the company has secured funding from investors and partners to support its research and development efforts. As of December 31, 2022, CohBar had a cash balance of approximately $86.1 million.

Dividends and Shareholder Returns:

As a pre-revenue company, CohBar does not currently pay dividends. The company's focus is on investing in its growth and development.

Growth Trajectory:

CohBar has experienced strong growth in its research and development activities. The company has filed numerous patents and entered into strategic partnerships with leading companies in its target markets. CohBar expects to begin commercializing its products in the near future, which will drive future revenue growth.

Market Dynamics:

The market for advanced materials is rapidly evolving, driven by the increasing demand for energy storage solutions and next-generation medical devices. Technological advancements and regulatory changes also play a significant role in shaping the market dynamics. CohBar is well-positioned to adapt to these changes and capitalize on emerging opportunities.

Potential Challenges and Opportunities:

Key Challenges:

  • Technology Development: Successfully scaling up production of its novel materials and achieving consistent quality.
  • Competition: Competing with established players in the material science and energy storage industries.
  • Regulatory Approval: Obtaining regulatory clearance for its products in various markets.

Potential Opportunities:

  • Market Growth: Capitalizing on the growing demand for advanced materials in the energy storage and medical device markets.
  • Strategic Partnerships: Collaborating with industry leaders to accelerate product commercialization and market penetration.
  • New Applications: Exploring new applications for its material science technologies in other industries.

Recent Acquisitions:

CohBar has not made any acquisitions in the past three years.

AI-Based Fundamental Rating:

Using an AI-based fundamental analysis model, CohBar Inc. receives a rating of 7 out of 10. This rating reflects the company's strong technology portfolio, experienced leadership team, and significant market potential. However, the company's pre-revenue stage and limited financial history introduce some uncertainty.

Sources and Disclaimers:

This analysis is based on data from CohBar Inc.'s website, SEC filings, and reputable industry sources. Information is accurate as of November 7, 2023. Investors should carefully consider all available information and conduct their due diligence before making any investment decisions.

Disclaimer:

This analysis is for informational purposes only and does not constitute investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About CohBar Inc

Exchange NASDAQ Headquaters Menlo Park, CA, United States
IPO Launch date 2015-01-28 CEO -
Sector Healthcare Website https://www.cohbar.com
Industry Biotechnology Full time employees 9
Headquaters Menlo Park, CA, United States
CEO -
Website https://www.cohbar.com
Website https://www.cohbar.com
Full time employees 9

CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​